Q3 saw a 7.8% drop in net sales and a negative EBITDA, mainly due to weak results in Vinga and Calormet, while Chemgroup and Geogruppen delivered strong growth. Management expects improved margins and profitability in Q4.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.